Shots:

• Astellas will construct the Third Fermentation Building as the manufacturing facility for API of Prograf (tacrolimus hydrate) in the Toyama Technology Center of Astellas Pharma
• The establishment of the new facility will enhance Astellas’ production capacity- enabling the stable supply of Prograf in future
• The total construction cost of the facility will be ~$90M with three above-ground floors having a total floor area of ~ 7-220 m². The construction is expected to be initiated in Apr’20 with its anticipated completion in Aug’21

Click here ­to­ read full press release/ article 

Ref: Astellas  | Image: Astellas